Using the PDX model, after treatment with gemcitabine, the Western blotting result showed that, tumor tissue with higher expression of FOXM1 presents higher p-P65 and Bcl2 levels and and low levels of Bax expression (Figure 3D). This evidence concerns the gene FOXM1 and neoplasm.